{"gene":"PHC2","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2005,"finding":"Phc2 is a constituent of class II PcG complexes (PRC1-type) and mediates polycomb repression of Hox cluster genes; coimmunoprecipitation from embryonic extracts confirmed physical association of Phc2 with Phc1 and Rnf110, and chromatin immunoprecipitation showed direct binding at the Hox locus. Genetic epistasis (synergistic posterior transformations in Phc2/Phc1 and Phc2/Rnf110 double mutants) placed Phc2 in the same pathway as these partners for anterior-posterior specification.","method":"Co-immunoprecipitation from embryonic extracts, chromatin immunoprecipitation with anti-Phc2 monoclonal antibodies, genetic epistasis analysis in double-mutant mice (Phc2/Phc1, Phc2/Rnf110), loss-of-function mouse model","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, ChIP, and genetic epistasis across multiple mutant combinations in a single rigorous study","pmids":["16024804"],"is_preprint":false},{"year":2005,"finding":"Loss of Phc2 in mouse embryonic fibroblasts causes premature senescence associated with derepression of Cdkn2a (p16/p19) genes, establishing a functional role for Phc2 in repressing the Cdkn2a locus.","method":"Loss-of-function mouse model (Phc2-knockout), cellular senescence assay, gene expression analysis of Cdkn2a in MEFs","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cellular phenotype, single lab, single paper","pmids":["16024804"],"is_preprint":false},{"year":2002,"finding":"Edr2 (Phc2) is transcribed as two isoforms encoding 90-kDa and 36-kDa polypeptides; the 36-kDa truncated form colocalizes with PcG protein Mel18 in nuclei, indicating it retains the capacity to associate with PcG complexes.","method":"cDNA cloning, genomic analysis, immunostaining of HA-tagged 36-kDa protein in mammalian cells","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — colocalization by immunostaining, single lab, two orthogonal methods (molecular cloning + imaging)","pmids":["12034499"],"is_preprint":false},{"year":2010,"finding":"SIAH-1 (an E3 ubiquitin ligase) directly interacts with HPH2 (PHC2) both in vitro and in vivo; the cysteine-rich region of SIAH-1 and the PxVxAxP motif of HPH2 are required for the interaction. SIAH-1 promotes ubiquitination and proteasomal degradation of HPH2, and this activity requires both E3 ligase activity and HPH2-binding ability of SIAH-1, identifying SIAH-1 as a direct E3 ligase for HPH2.","method":"In vitro binding assay, co-immunoprecipitation in vivo, ubiquitination assay, proteasome inhibitor experiments, domain-mapping mutagenesis of SIAH-1","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro binding reconstitution plus in vivo Co-IP plus mutagenesis of active site and binding interface, single lab","pmids":["20471960"],"is_preprint":false},{"year":2019,"finding":"Phc2 represses Vcam1 expression in bone marrow stromal cells (BMSCs) via H3K27me3 and H2AK119ub epigenetic marks; genetic ablation of Phc2 causes derepression of Vcam1 in BMSCs, leading to a severe defect in HSPC mobilization from bone marrow and systemic immunodeficiency. Pharmacological inhibition of VCAM-1 in Phc2-deficient mice reverses the mobilization defect.","method":"Phc2-knockout mouse model, chromatin mark analysis (H3K27me3, H2AK119ub), pharmacological rescue with VCAM-1 inhibitor, HSPC mobilization assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined cellular phenotype, epigenetic mechanistic readout (H3K27me3/H2AK119ub at Vcam1), pharmacological rescue, multiple orthogonal methods in single rigorous study","pmids":["31375680"],"is_preprint":false},{"year":2013,"finding":"Ectopic expression of Phc2 in helper T (Th) cells inhibits Th cell proliferation and IL-2 secretion upon antigen-specific activation, demonstrating a negative regulatory role for Phc2 in Th cell activation.","method":"Overexpression in primary Th cells, cell proliferation assay, IL-2 secretion measurement upon antigen-specific stimulation","journal":"In vitro cellular & developmental biology. Animal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — gain-of-function overexpression with phenotypic readout, no mechanistic pathway placement, single lab, single method","pmids":["23605804"],"is_preprint":false},{"year":2024,"finding":"CBX7C (a splicing isoform of CBX7) preferentially interacts with PHC2 to facilitate PRC1 complex assembly on chromatin. At low levels, the CBX7C·PHC2 interaction promotes formation of functional, high-mobility Polycomb bodies; at high levels, the interaction leads to large, low-mobility, chromatin-free aggregates, demonstrating that the CBX7C·PHC2 interaction modulates PRC1 phase separation properties.","method":"Co-immunoprecipitation (CBX7C·PHC2 interaction), knockdown of Cbx7C in mESCs, live-cell imaging of Polycomb bodies (mobility measurements), overexpression titration experiments, embryoid body differentiation assays","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus live imaging with functional consequence, single lab, multiple orthogonal methods","pmids":["38600974"],"is_preprint":false}],"current_model":"PHC2 (also known as HPH2/EDR2) is a nuclear subunit of Polycomb Repressive Complex 1 (PRC1) that physically associates with Phc1, Rnf110, and CBX7C to mediate H3K27me3/H2AK119ub-dependent transcriptional repression of Hox genes and Cdkn2a, controls HSPC mobilization by repressing Vcam1 in bone marrow stromal cells, and acts as a negative regulator of helper T cell activation; its protein levels are regulated by the E3 ubiquitin ligase SIAH-1 via the ubiquitin-proteasome pathway, and its interaction with CBX7C modulates PRC1 phase separation and Polycomb body dynamics."},"narrative":{"mechanistic_narrative":"PHC2 (HPH2/EDR2) is a nuclear subunit of Polycomb Repressive Complex 1 (PRC1) that mediates H3K27me3/H2AK119ub-dependent transcriptional repression across developmental and homeostatic gene programs [PMID:16024804, PMID:31375680]. Within PRC1, PHC2 physically associates with Phc1 and Rnf110, occupies the Hox locus directly, and acts in the same genetic pathway as these partners for anterior-posterior axis specification, with double mutants showing synergistic posterior transformations [PMID:16024804]. PHC2-dependent repression extends to the Cdkn2a (p16/p19) locus, where loss of Phc2 derepresses Cdkn2a and triggers premature senescence in fibroblasts [PMID:16024804], and to Vcam1 in bone marrow stromal cells, where Phc2 deletion derepresses Vcam1 and produces a severe HSPC mobilization defect that is reversed by VCAM-1 inhibition [PMID:31375680]. Assembly and biophysical behavior of PRC1 are tuned through a preferential interaction between PHC2 and the CBX7C isoform, which governs Polycomb body formation and phase-separation properties in a dose-dependent manner [PMID:38600974]. PHC2 protein abundance is set post-translationally by the E3 ubiquitin ligase SIAH-1, which binds the PxVxAxP motif of PHC2 and targets it for ubiquitin-proteasome degradation [PMID:20471960].","teleology":[{"year":2002,"claim":"Established that EDR2/PHC2 is expressed as two isoforms and that the truncated form retains PcG-association capacity, the first link of the gene product to Polycomb machinery.","evidence":"cDNA/genomic cloning and immunostaining of HA-tagged 36-kDa protein colocalizing with Mel18 in mammalian nuclei","pmids":["12034499"],"confidence":"Medium","gaps":["Colocalization does not demonstrate direct physical interaction with PcG complex subunits","Functional role of the two isoforms not distinguished","No chromatin target identified"]},{"year":2005,"claim":"Defined PHC2 as a bona fide PRC1-type subunit that directly represses Hox genes, answering whether it functions within a defined complex and pathway.","evidence":"Co-IP from embryonic extracts, anti-Phc2 ChIP at Hox locus, and genetic epistasis in Phc2/Phc1 and Phc2/Rnf110 double-mutant mice","pmids":["16024804"],"confidence":"High","gaps":["Stoichiometry and architecture within PRC1 not resolved","Mechanism of recruitment to Hox chromatin unknown","Direct catalytic contribution of PHC2 to histone marks not established"]},{"year":2005,"claim":"Extended PHC2 repressive function to the Cdkn2a locus, connecting Polycomb activity to cellular senescence control.","evidence":"Phc2-knockout MEFs showing Cdkn2a (p16/p19) derepression and premature senescence","pmids":["16024804"],"confidence":"Medium","gaps":["Direct PHC2 binding at Cdkn2a not shown","Whether senescence is cell-autonomous to PRC1 activity not separated from indirect effects","Single lab/single study"]},{"year":2010,"claim":"Identified how PHC2 levels are controlled, showing SIAH-1 as a direct E3 ligase that targets PHC2 for degradation.","evidence":"In vitro binding, in vivo Co-IP, ubiquitination and proteasome-inhibitor assays, and domain mapping of the SIAH-1 cysteine-rich region and PHC2 PxVxAxP motif","pmids":["20471960"],"confidence":"High","gaps":["Physiological context regulating SIAH-1-mediated PHC2 turnover unknown","Consequence of PHC2 degradation for PRC1 activity not measured","Whether degradation is locus- or signal-specific not addressed"]},{"year":2013,"claim":"Provided a first phenotypic link of PHC2 to immune regulation, indicating a negative role in helper T cell activation.","evidence":"Ectopic Phc2 expression in primary Th cells with proliferation and IL-2 secretion readouts after antigen-specific stimulation","pmids":["23605804"],"confidence":"Low","gaps":["Gain-of-function overexpression without loss-of-function confirmation","No mechanistic pathway or chromatin target identified","Single lab, single method"]},{"year":2019,"claim":"Established a specific in vivo target and physiological program, showing PHC2 represses Vcam1 in bone marrow stromal cells to enable HSPC mobilization.","evidence":"Phc2-knockout mice, H3K27me3/H2AK119ub mark analysis at Vcam1, HSPC mobilization assays, and pharmacological VCAM-1 inhibition rescue","pmids":["31375680"],"confidence":"High","gaps":["How PHC2/PRC1 is targeted specifically to Vcam1 in BMSCs unknown","Relationship to the T-cell phenotype not integrated","Cell-type specificity of PHC2 targets not mapped"]},{"year":2024,"claim":"Resolved how a PRC1 subunit composition choice tunes complex behavior, showing the CBX7C·PHC2 interaction governs Polycomb body assembly and phase separation.","evidence":"Reciprocal Co-IP, Cbx7C knockdown in mESCs, live-cell imaging of Polycomb body mobility, overexpression titration, and embryoid body differentiation assays","pmids":["38600974"],"confidence":"Medium","gaps":["Structural basis of CBX7C·PHC2 preference not defined","Functional gene targets affected by altered phase separation not enumerated","Single lab/single study"]},{"year":null,"claim":"How PHC2 target specificity is achieved across distinct cell types (Hox, Cdkn2a, Vcam1) and how its SIAH-1-mediated turnover is physiologically triggered remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of PHC2 within PRC1","Recruitment determinants to specific loci unknown","Signals controlling SIAH-1-dependent PHC2 degradation in vivo undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,4]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,4]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,4]}],"complexes":["PRC1"],"partners":["PHC1","RNF110","SIAH1","CBX7","MEL18"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8IXK0","full_name":"Polyhomeotic-like protein 2","aliases":["Early development regulatory protein 2"],"length_aa":858,"mass_kda":90.7,"function":"Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8IXK0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PHC2","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HIST2H2BE","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PHC2","total_profiled":1310},"omim":[{"mim_id":"620493","title":"STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 7; SAMD7","url":"https://www.omim.org/entry/620493"},{"mim_id":"616396","title":"SCM POLYCOMB GROUP PROTEIN HOMOLOG 1; SCMH1","url":"https://www.omim.org/entry/616396"},{"mim_id":"602979","title":"POLYHOMEOTIC HOMOLOG 2; PHC2","url":"https://www.omim.org/entry/602979"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PHC2"},"hgnc":{"alias_symbol":["HPH2"],"prev_symbol":["EDR2"]},"alphafold":{"accession":"Q8IXK0","domains":[{"cath_id":"-","chopping":"640-672","consensus_level":"high","plddt":87.6661,"start":640,"end":672},{"cath_id":"1.10.150.50","chopping":"792-858","consensus_level":"high","plddt":93.819,"start":792,"end":858}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IXK0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IXK0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IXK0-F1-predicted_aligned_error_v6.png","plddt_mean":50.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PHC2","jax_strain_url":"https://www.jax.org/strain/search?query=PHC2"},"sequence":{"accession":"Q8IXK0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IXK0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IXK0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IXK0"}},"corpus_meta":[{"pmid":"16024804","id":"PMC_16024804","title":"Mammalian polyhomeotic homologues Phc2 and Phc1 act in synergy to mediate polycomb repression of Hox genes.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16024804","citation_count":117,"is_preprint":false},{"pmid":"31375680","id":"PMC_31375680","title":"Phc2 controls hematopoietic stem and progenitor cell mobilization from bone marrow by repressing Vcam1 expression.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31375680","citation_count":17,"is_preprint":false},{"pmid":"21097665","id":"PMC_21097665","title":"Hph1 and Hph2 are novel components of the Sec63/Sec62 posttranslational translocation complex that aid in vacuolar proton ATPase biogenesis.","date":"2010","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/21097665","citation_count":15,"is_preprint":false},{"pmid":"12034499","id":"PMC_12034499","title":"The mouse Edr2 (Mph2) gene has two forms of mRNA encoding 90- and 36-kDa polypeptides.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12034499","citation_count":9,"is_preprint":false},{"pmid":"20471960","id":"PMC_20471960","title":"SIAH-1 interacts with mammalian polyhomeotic homologues HPH2 and affects its stability via the ubiquitin-proteasome pathway.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20471960","citation_count":8,"is_preprint":false},{"pmid":"23605804","id":"PMC_23605804","title":"Expression pattern and functional role of Phc2 during activation of helper T cells after antigenic stimulation.","date":"2013","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/23605804","citation_count":7,"is_preprint":false},{"pmid":"9060407","id":"PMC_9060407","title":"Genetic mapping of hph2, a mutation affecting amino acid transport in the mouse.","date":"1997","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/9060407","citation_count":6,"is_preprint":false},{"pmid":"38600974","id":"PMC_38600974","title":"CBX7C⋅PHC2 interaction facilitates PRC1 assembly and modulates its phase separation properties.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38600974","citation_count":2,"is_preprint":false},{"pmid":"8190122","id":"PMC_8190122","title":"Regulation of polyunsaturated fat induced postprandial hypercholesterolemia by a novel gene Phc-2.","date":"1994","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8190122","citation_count":1,"is_preprint":false},{"pmid":"41925952","id":"PMC_41925952","title":"PHC2 as a novel predictive biomarker and therapeutic target for cisplatin resistance in lung adenocarcinoma.","date":"2026","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41925952","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6915,"output_tokens":2058,"usd":0.025808,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8971,"output_tokens":2800,"usd":0.057427,"stage2_stop_reason":"end_turn"},"total_usd":0.083235,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"Phc2 is a constituent of class II PcG complexes (PRC1-type) and mediates polycomb repression of Hox cluster genes; coimmunoprecipitation from embryonic extracts confirmed physical association of Phc2 with Phc1 and Rnf110, and chromatin immunoprecipitation showed direct binding at the Hox locus. Genetic epistasis (synergistic posterior transformations in Phc2/Phc1 and Phc2/Rnf110 double mutants) placed Phc2 in the same pathway as these partners for anterior-posterior specification.\",\n      \"method\": \"Co-immunoprecipitation from embryonic extracts, chromatin immunoprecipitation with anti-Phc2 monoclonal antibodies, genetic epistasis analysis in double-mutant mice (Phc2/Phc1, Phc2/Rnf110), loss-of-function mouse model\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, ChIP, and genetic epistasis across multiple mutant combinations in a single rigorous study\",\n      \"pmids\": [\"16024804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Loss of Phc2 in mouse embryonic fibroblasts causes premature senescence associated with derepression of Cdkn2a (p16/p19) genes, establishing a functional role for Phc2 in repressing the Cdkn2a locus.\",\n      \"method\": \"Loss-of-function mouse model (Phc2-knockout), cellular senescence assay, gene expression analysis of Cdkn2a in MEFs\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cellular phenotype, single lab, single paper\",\n      \"pmids\": [\"16024804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Edr2 (Phc2) is transcribed as two isoforms encoding 90-kDa and 36-kDa polypeptides; the 36-kDa truncated form colocalizes with PcG protein Mel18 in nuclei, indicating it retains the capacity to associate with PcG complexes.\",\n      \"method\": \"cDNA cloning, genomic analysis, immunostaining of HA-tagged 36-kDa protein in mammalian cells\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — colocalization by immunostaining, single lab, two orthogonal methods (molecular cloning + imaging)\",\n      \"pmids\": [\"12034499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SIAH-1 (an E3 ubiquitin ligase) directly interacts with HPH2 (PHC2) both in vitro and in vivo; the cysteine-rich region of SIAH-1 and the PxVxAxP motif of HPH2 are required for the interaction. SIAH-1 promotes ubiquitination and proteasomal degradation of HPH2, and this activity requires both E3 ligase activity and HPH2-binding ability of SIAH-1, identifying SIAH-1 as a direct E3 ligase for HPH2.\",\n      \"method\": \"In vitro binding assay, co-immunoprecipitation in vivo, ubiquitination assay, proteasome inhibitor experiments, domain-mapping mutagenesis of SIAH-1\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro binding reconstitution plus in vivo Co-IP plus mutagenesis of active site and binding interface, single lab\",\n      \"pmids\": [\"20471960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Phc2 represses Vcam1 expression in bone marrow stromal cells (BMSCs) via H3K27me3 and H2AK119ub epigenetic marks; genetic ablation of Phc2 causes derepression of Vcam1 in BMSCs, leading to a severe defect in HSPC mobilization from bone marrow and systemic immunodeficiency. Pharmacological inhibition of VCAM-1 in Phc2-deficient mice reverses the mobilization defect.\",\n      \"method\": \"Phc2-knockout mouse model, chromatin mark analysis (H3K27me3, H2AK119ub), pharmacological rescue with VCAM-1 inhibitor, HSPC mobilization assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined cellular phenotype, epigenetic mechanistic readout (H3K27me3/H2AK119ub at Vcam1), pharmacological rescue, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"31375680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Ectopic expression of Phc2 in helper T (Th) cells inhibits Th cell proliferation and IL-2 secretion upon antigen-specific activation, demonstrating a negative regulatory role for Phc2 in Th cell activation.\",\n      \"method\": \"Overexpression in primary Th cells, cell proliferation assay, IL-2 secretion measurement upon antigen-specific stimulation\",\n      \"journal\": \"In vitro cellular & developmental biology. Animal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — gain-of-function overexpression with phenotypic readout, no mechanistic pathway placement, single lab, single method\",\n      \"pmids\": [\"23605804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CBX7C (a splicing isoform of CBX7) preferentially interacts with PHC2 to facilitate PRC1 complex assembly on chromatin. At low levels, the CBX7C·PHC2 interaction promotes formation of functional, high-mobility Polycomb bodies; at high levels, the interaction leads to large, low-mobility, chromatin-free aggregates, demonstrating that the CBX7C·PHC2 interaction modulates PRC1 phase separation properties.\",\n      \"method\": \"Co-immunoprecipitation (CBX7C·PHC2 interaction), knockdown of Cbx7C in mESCs, live-cell imaging of Polycomb bodies (mobility measurements), overexpression titration experiments, embryoid body differentiation assays\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus live imaging with functional consequence, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"38600974\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PHC2 (also known as HPH2/EDR2) is a nuclear subunit of Polycomb Repressive Complex 1 (PRC1) that physically associates with Phc1, Rnf110, and CBX7C to mediate H3K27me3/H2AK119ub-dependent transcriptional repression of Hox genes and Cdkn2a, controls HSPC mobilization by repressing Vcam1 in bone marrow stromal cells, and acts as a negative regulator of helper T cell activation; its protein levels are regulated by the E3 ubiquitin ligase SIAH-1 via the ubiquitin-proteasome pathway, and its interaction with CBX7C modulates PRC1 phase separation and Polycomb body dynamics.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PHC2 (HPH2/EDR2) is a nuclear subunit of Polycomb Repressive Complex 1 (PRC1) that mediates H3K27me3/H2AK119ub-dependent transcriptional repression across developmental and homeostatic gene programs [#0, #4]. Within PRC1, PHC2 physically associates with Phc1 and Rnf110, occupies the Hox locus directly, and acts in the same genetic pathway as these partners for anterior-posterior axis specification, with double mutants showing synergistic posterior transformations [#0]. PHC2-dependent repression extends to the Cdkn2a (p16/p19) locus, where loss of Phc2 derepresses Cdkn2a and triggers premature senescence in fibroblasts [#1], and to Vcam1 in bone marrow stromal cells, where Phc2 deletion derepresses Vcam1 and produces a severe HSPC mobilization defect that is reversed by VCAM-1 inhibition [#4]. Assembly and biophysical behavior of PRC1 are tuned through a preferential interaction between PHC2 and the CBX7C isoform, which governs Polycomb body formation and phase-separation properties in a dose-dependent manner [#6]. PHC2 protein abundance is set post-translationally by the E3 ubiquitin ligase SIAH-1, which binds the PxVxAxP motif of PHC2 and targets it for ubiquitin-proteasome degradation [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established that EDR2/PHC2 is expressed as two isoforms and that the truncated form retains PcG-association capacity, the first link of the gene product to Polycomb machinery.\",\n      \"evidence\": \"cDNA/genomic cloning and immunostaining of HA-tagged 36-kDa protein colocalizing with Mel18 in mammalian nuclei\",\n      \"pmids\": [\"12034499\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Colocalization does not demonstrate direct physical interaction with PcG complex subunits\", \"Functional role of the two isoforms not distinguished\", \"No chromatin target identified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined PHC2 as a bona fide PRC1-type subunit that directly represses Hox genes, answering whether it functions within a defined complex and pathway.\",\n      \"evidence\": \"Co-IP from embryonic extracts, anti-Phc2 ChIP at Hox locus, and genetic epistasis in Phc2/Phc1 and Phc2/Rnf110 double-mutant mice\",\n      \"pmids\": [\"16024804\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Stoichiometry and architecture within PRC1 not resolved\", \"Mechanism of recruitment to Hox chromatin unknown\", \"Direct catalytic contribution of PHC2 to histone marks not established\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extended PHC2 repressive function to the Cdkn2a locus, connecting Polycomb activity to cellular senescence control.\",\n      \"evidence\": \"Phc2-knockout MEFs showing Cdkn2a (p16/p19) derepression and premature senescence\",\n      \"pmids\": [\"16024804\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct PHC2 binding at Cdkn2a not shown\", \"Whether senescence is cell-autonomous to PRC1 activity not separated from indirect effects\", \"Single lab/single study\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified how PHC2 levels are controlled, showing SIAH-1 as a direct E3 ligase that targets PHC2 for degradation.\",\n      \"evidence\": \"In vitro binding, in vivo Co-IP, ubiquitination and proteasome-inhibitor assays, and domain mapping of the SIAH-1 cysteine-rich region and PHC2 PxVxAxP motif\",\n      \"pmids\": [\"20471960\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Physiological context regulating SIAH-1-mediated PHC2 turnover unknown\", \"Consequence of PHC2 degradation for PRC1 activity not measured\", \"Whether degradation is locus- or signal-specific not addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided a first phenotypic link of PHC2 to immune regulation, indicating a negative role in helper T cell activation.\",\n      \"evidence\": \"Ectopic Phc2 expression in primary Th cells with proliferation and IL-2 secretion readouts after antigen-specific stimulation\",\n      \"pmids\": [\"23605804\"],\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Gain-of-function overexpression without loss-of-function confirmation\", \"No mechanistic pathway or chromatin target identified\", \"Single lab, single method\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established a specific in vivo target and physiological program, showing PHC2 represses Vcam1 in bone marrow stromal cells to enable HSPC mobilization.\",\n      \"evidence\": \"Phc2-knockout mice, H3K27me3/H2AK119ub mark analysis at Vcam1, HSPC mobilization assays, and pharmacological VCAM-1 inhibition rescue\",\n      \"pmids\": [\"31375680\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"How PHC2/PRC1 is targeted specifically to Vcam1 in BMSCs unknown\", \"Relationship to the T-cell phenotype not integrated\", \"Cell-type specificity of PHC2 targets not mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved how a PRC1 subunit composition choice tunes complex behavior, showing the CBX7C·PHC2 interaction governs Polycomb body assembly and phase separation.\",\n      \"evidence\": \"Reciprocal Co-IP, Cbx7C knockdown in mESCs, live-cell imaging of Polycomb body mobility, overexpression titration, and embryoid body differentiation assays\",\n      \"pmids\": [\"38600974\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Structural basis of CBX7C·PHC2 preference not defined\", \"Functional gene targets affected by altered phase separation not enumerated\", \"Single lab/single study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PHC2 target specificity is achieved across distinct cell types (Hox, Cdkn2a, Vcam1) and how its SIAH-1-mediated turnover is physiologically triggered remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No structural model of PHC2 within PRC1\", \"Recruitment determinants to specific loci unknown\", \"Signals controlling SIAH-1-dependent PHC2 degradation in vivo undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 4]}\n    ],\n    \"complexes\": [\"PRC1\"],\n    \"partners\": [\"PHC1\", \"RNF110\", \"SIAH1\", \"CBX7\", \"MEL18\"],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}